These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Peritoneovenous shunt in the treatment of therapy resistant ascites. Results of 7 years' experience].
    Author: Zühlke HV, Häring R, Semsch B.
    Journal: Chirurg; 1984 Apr; 55(4):253-9. PubMed ID: 6723465.
    Abstract:
    In recent years, implantation of a peritoneo-venous shunt has proven effective in the treatment of therapy-resistant ascites. From 1976 till 1983, a total of 63 shunt systems (Le Veen-, Agishi -, Denver system) were implanted in 55 patients with a mean age of 52.3 years. The most common cause for ascites was hepatic cirrhosis. The average functional period amounted to 21.7 months and the longest implantation time to nearly 7 years. The postoperative complication rate is considerable: 19 patients died in the postoperative course. The most dreaded complication is shunt infection and intravascular thrombopathy . In spite of the high complication rate, the establishment of a peritoneo-venous shunt is recommendable for combatting therapy-resistant ascites.
    [Abstract] [Full Text] [Related] [New Search]